Lauk O - Search Results

1

Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.

Opitz I, Lauk O, Meerang M, Jetter A, Aeschlimann B, Seifert B, Günther D, Stahel RA, Weder W. Opitz I, et al. Among authors: lauk o. J Thorac Cardiovasc Surg. 2020 Jan;159(1):330-340.e4. doi: 10.1016/j.jtcvs.2019.07.073. Epub 2019 Aug 22. J Thorac Cardiovasc Surg. 2020. PMID: 31590949 Free article.

2

Extrapleural pneumonectomy after induction chemotherapy: perioperative outcome in 251 mesothelioma patients from three high-volume institutions.

Lauk O, Hoda MA, de Perrot M, Friess M, Klikovits T, Klepetko W, Keshavjee S, Weder W, Opitz I. Lauk O, et al. Ann Thorac Surg. 2014 Nov;98(5):1748-54. doi: 10.1016/j.athoracsur.2014.05.071. Epub 2014 Aug 7. Ann Thorac Surg. 2014. PMID: 25110339 Clinical Trial.

3

Evaluation of imaging techniques for the assessment of tumour progression in an orthotopic rat model of malignant pleural mesothelioma†.

Meerang M, Boss A, Kenkel D, Broggini-Tenzer A, Bérard K, Lauk O, Arni S, Weder W, Opitz I. Meerang M, et al. Among authors: lauk o. Eur J Cardiothorac Surg. 2015 Jan;47(1):e34-41. doi: 10.1093/ejcts/ezu393. Epub 2014 Oct 25. Eur J Cardiothorac Surg. 2015. PMID: 25344922 Free article.

4

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.

Carbone M, Flores EG, Emi M, Johnson TA, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Powers A, Minaai M, Baumann F, Bryant-Greenwood P, Lauk O, Kirschner MB, Weder W, Opitz I, Pass HI, Gaudino G, Pastorino S, Yang H. Carbone M, et al. Among authors: lauk o. PLoS Genet. 2015 Dec 18;11(12):e1005633. doi: 10.1371/journal.pgen.1005633. eCollection 2015 Dec. PLoS Genet. 2015. PMID: 26683624 Free PMC article.

5

Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.

Meerang M, Bérard K, Felley-Bosco E, Lauk O, Vrugt B, Boss A, Kenkel D, Broggini-Tenzer A, Stahel RA, Arni S, Weder W, Opitz I. Meerang M, et al. Among authors: lauk o. Mol Cancer Ther. 2016 May;15(5):1095-105. doi: 10.1158/1535-7163.MCT-15-0583. Epub 2016 Feb 2. Mol Cancer Ther. 2016. PMID: 26839306 Free article.

6

Intraluminal EWSR1-CREB1 gene rearranged, low-grade myxoid sarcoma of the pulmonary artery resembling extraskeletal myxoid chondrosarcoma (EMC).

Opitz I, Lauk O, Schneiter D, Ulrich S, Maisano F, Weder W, Bode-Lesniewska B. Opitz I, et al. Among authors: lauk o. Histopathology. 2019 Feb;74(3):526-530. doi: 10.1111/his.13773. Epub 2018 Dec 5. Histopathology. 2019. PMID: 30326150 Free article. No abstract available.

7

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.

Schröder C, Opitz I, Guckenberger M, Stahel R, Weder W, Förster R, Andratschke N, Lauk O. Schröder C, et al. Among authors: lauk o. Front Oncol. 2019 Sep 26;9:961. doi: 10.3389/fonc.2019.00961. eCollection 2019. Front Oncol. 2019. PMID: 31616640 Free PMC article.

8

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial.

Hiltbrunner S, Britschgi C, Schuberth P, Bankel L, Nguyen-Kim TDL, Gulati P, Weder W, Opitz I, Lauk O, Caviezel C, Bachmann H, Tabor A, Schröder P, Knuth A, Münz C, Stahel R, Boyman O, Renner C, Petrausch U, Curioni-Fontecedro A. Hiltbrunner S, et al. Among authors: lauk o. Ann Oncol. 2021 Jan;32(1):120-121. doi: 10.1016/j.annonc.2020.10.474. Epub 2020 Oct 21. Ann Oncol. 2021. PMID: 33098996 Free article. Clinical Trial. No abstract available.

9

The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis.

Lauk O, Bruestle K, Neuer T, Battilana B, Nguyen TDL, Frauenfelder T, Stahel R, Weder W, Curioni-Fontecedro A, Opitz I. Lauk O, et al. Front Oncol. 2020 Nov 13;10:588563. doi: 10.3389/fonc.2020.588563. eCollection 2020. Front Oncol. 2020. PMID: 33304848 Free PMC article.

10

Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.

Lauk O, Patella M, Neuer T, Battilana B, Frauenfelder T, Nguyen-Kim TDL, Weder W, Caviezel C, Hillinger S, Inci I, Opitz I. Lauk O, et al. Cancer Imaging. 2021 Aug 3;21(1):48. doi: 10.1186/s40644-021-00415-5. Cancer Imaging. 2021. PMID: 34344472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters